Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             68 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 Applicability of the EORTC/MSG criteria for IFD in clinical practice Rieger, H.
2014
94 Suppl 1 p. 847-855
artikel
2 A prospective study of incidence, clinical and quality of life consequences of oral mucositis post palifermin prophylaxis in patients undergoing high-dose chemotherapy and autologous hematopoietic cell transplantation Sakellari, Ioanna
2015
94 Suppl 1 p. 1733-1740
artikel
3 A review of the European LeukemiaNet recommendations for the management of CML Baccarani, Michele
2015
94 Suppl 1 p. 141-147
artikel
4 Bendamustine as first-line treatment in patients with advanced indolent non-Hodgkin lymphoma and mantle cell lymphoma in German routine clinical practice Becker, M.
2015
94 Suppl 1 p. 1553-1558
artikel
5 Bendamustine in combination with thalidomide and dexamethasone is a viable salvage option in myeloma relapsed and/or refractory to bortezomib and lenalidomide Lau, I-Jun
2014
94 Suppl 1 p. 643-649
artikel
6 Big data analysis of treatment patterns and outcomes among elderly acute myeloid leukemia patients in the United States Medeiros, Bruno C.
2015
94 Suppl 1 p. 1127-1138
artikel
7 Causes of resistance and treatment choices of second- and third-line treatment in chronic myelogenous leukemia patients Hochhaus, Andreas
2015
94 Suppl 1 p. 133-140
artikel
8 CD4+ T cell counts reflect the immunosuppressive state of CD4 helper cells in patients after allogeneic stem cell transplantation Holtick, Udo
2014
94 Suppl 1 p. 129-137
artikel
9 CML—where do we stand in 2015? Hehlmann, Rüdiger
2015
94 Suppl 1 p. 103-105
artikel
10 Cytomegalovirus infection in seropositive unrelated cord blood recipients: a study of 349 Korean patients Park, Meerim

94 Suppl 1 p. 481-489
artikel
11 Cytomegalovirus reactivation with bendamustine in patients with low-grade B-cell lymphoma Hasegawa, Tetsuo
2014
94 Suppl 1 p. 515-517
artikel
12 Danazol therapy for the anemia of myelofibrosis: assessment of efficacy with current criteria of response and long-term results Cervantes, Francisco
2015
94 Suppl 1 p. 1791-1796
artikel
13 Desmopressin improves platelet function in uremic patients taking antiplatelet agents who require emergent invasive procedures Kim, Ji Hyun
2015
94 Suppl 1 p. 1457-1461
artikel
14 Diverse phenotypes and transfusion requirements due to interaction of β-thalassemias with triplicated α-globin genes Mehta, Pallavi R.
2015
94 Suppl 1 p. 1953-1958
artikel
15 Early CMV replication and subsequent chronic GVHD have a significant anti-leukemic effect after allogeneic HSCT in acute myeloid leukemia Jang, Ji Eun
2014
94 Suppl 1 p. 275-282
artikel
16 Enhanced human mesenchymal stem cell survival under oxidative stress by overexpression of secreted frizzled-related protein 2 gene Pomduk, Kanjana
2014
94 Suppl 1 p. 319-327
artikel
17 Erlotinib is not effective in patients with JAK2V617F-positive polycythemia vera Cherry, Mohamad
2014
94 Suppl 1 p. 717-719
artikel
18 Evolution of iron overload in patients with low-risk myelodysplastic syndrome: iron chelation therapy and organ complications Remacha, Ángel F.
2014
94 Suppl 1 p. 779-787
artikel
19 Fatal pulmonary hemorrhage after carfilzomib treatment in multiple myeloma Kwong, Yok-Lam
2015
94 Suppl 1 p. 1425-1426
artikel
20 First-line treatments for chronic lymphocytic leukaemia: interpreting efficacy data by network meta-analysis Messori, Andrea
2015
94 Suppl 1 p. 1003-1009
artikel
21 GATA2 mutations in patients with acute myeloid leukemia-paired samples analyses show that the mutation is unstable during disease evolution Hou, Hsin-An
2014
94 Suppl 1 p. 211-221
artikel
22 Headache prevalence following recovery from TTP and aHUS Saultz, Jennifer N.
2015
94 Suppl 1 p. 1473-1476
artikel
23 Heparanase procoagulant activity, factor Xa, and plasminogen activator inhibitor 1 are increased in shift work female nurses Nadir, Yona
2015
94 Suppl 1 p. 1213-1219
artikel
24 Idarubicin and cytarabine in combination with gemtuzumab ozogamicin (IAGO) for untreated patients with high-risk MDS or AML evolved from MDS: a phase II study from the EORTC and GIMEMA Leukemia Groups (protocol 06013) Witte, Theo de
2015
94 Suppl 1 p. 1981-1989
artikel
25 Improved outcome of pediatric patients with acute megakaryoblastic leukemia in the AML-BFM 04 trial Schweitzer, Jana
2015
94 Suppl 1 p. 1327-1336
artikel
26 Incidence of testicular microlithiasis in patients with β-thalassemia major Rahimi, Rahil
2015
94 Suppl 1 p. 1785-1789
artikel
27 Is there any complimentary role of F-18 NaF PET/CT in detecting of osseous involvement of multiple myeloma? A comparative study for F-18 FDG PET/CT and F-18 FDG NaF PET/CT Ak, İlknur
2015
94 Suppl 1 p. 1567-1575
artikel
28 Krüppel-like factor 1 mutations and expression of hemoglobins F and A2 in homozygous hemoglobin E syndrome Tepakhan, Wanicha
2015
94 Suppl 1 p. 1093-1098
artikel
29 Leishmaniasis involving the bone marrow of a patient with multiple myeloma Alahmadi, M.
2015
94 Suppl 1 p. 1417-1418
artikel
30 Limited duration of complete remission on ruxolitinib in myeloid neoplasms with PCM1-JAK2 and BCR-JAK2 fusion genes Schwaab, Juliana
2014
94 Suppl 1 p. 233-238
artikel
31 Low levels of CD9 coincidental with a novel nonsense mutation in glycoprotein Ibβ in a patient with Bernard-Soulier syndrome Qiao, Jianlin
2015
94 Suppl 1 p. 2069-2071
artikel
32 Management of adverse events associated with tyrosine kinase inhibitors in chronic myeloid leukemia Rea, Delphine
2015
94 Suppl 1 p. 149-158
artikel
33 Modified ESHAP regimen for relapsed/refractory T cell lymphoma: a retrospective analysis Kogure, Yasunori
2015
94 Suppl 1 p. 989-994
artikel
34 Molecular analysis of loss of CCR4 expression during mogamulizumab monotherapy in an adult T cell leukemia/lymphoma patient Taguchi, Masataka
2014
94 Suppl 1 p. 693-695
artikel
35 Molecular monitoring of chronic myeloid leukemia: principles and interlaboratory standardization Cross, Nicholas C. P.
2015
94 Suppl 1 p. 219-225
artikel
36 Nonmyeloablative allogeneic stem cell transplantation for chronic lymphocytic leukaemia offers the possibility of disease control with minimal morbidity and mortality—a single institution experience Chakupurakal, G.
2015
94 Suppl 1 p. 1717-1725
artikel
37 Non-pegylated liposomal doxorubicin in lymphoma: patterns of toxicity and outcome in a large observational trial Wasle, Ines
2014
94 Suppl 1 p. 593-601
artikel
38 Oral beclomethasone dipropionate as an initial treatment for stages 1–2 gastrointestinal tract acute graft-versus-host disease following unrelated cord blood transplantation Yamamoto, Hisashi
2015
94 Suppl 1 p. 2073-2075
artikel
39 Osteopontin: a potential biomarker of Gaucher disease Vairo, Filippo
2015
94 Suppl 1 p. 1119-1125
artikel
40 Paraneoplastic pemphigus occurring after bendamustine and rituximab therapy for relapsed follicular lymphoma Higo, Takashi
2014
94 Suppl 1 p. 683-685
artikel
41 Pharmacokinetics for once-daily modified release formulation of tacrolimus hydrate in unrelated hematopoietic stem cell transplantation Yano, Shingo
2014
94 Suppl 1 p. 491-496
artikel
42 Phase II study of bendamustine combined with rituximab in relapsed/refractory mantle cell lymphoma: efficacy, tolerability, and safety findings Czuczman, Myron S.
2015
94 Suppl 1 p. 2025-2032
artikel
43 Prediction of central venous catheter–related bloodstream infections (CRBSIs) in patients with haematologic malignancies using a modified Infection Probability Score (mIPS) Schalk, Enrico
2015
94 Suppl 1 p. 1451-1456
artikel
44 Pretransplantation use of the second-generation tyrosine kinase inhibitors has no negative impact on the HCT outcome Piekarska, Agnieszka
2015
94 Suppl 1 p. 1891-1897
artikel
45 Prognosis of patients with diffuse large B cell lymphoma not reaching complete response or relapsing after frontline chemotherapy or immunochemotherapy Rovira, Jordina
2014
94 Suppl 1 p. 803-812
artikel
46 Prognostic significance of diagnosed WT1 level in acute myeloid leukemia: a meta-analysis Yi-ning, Yang
2015
94 Suppl 1 p. 929-938
artikel
47 Programmed death-1 (PD-1), programmed death-ligand 1 (PD-L1), and EBV-encoded RNA (EBER) expression in Hodgkin lymphoma Paydas, Semra
2015
94 Suppl 1 p. 1545-1552
artikel
48 Prolonged clinical remissions in patients with relapsed or refractory follicular lymphoma treated with autologous stem cell transplantation incorporating rituximab Berinstein, N. L.
2015
94 Suppl 1 p. 813-823
artikel
49 Prospective study of prognostic factors in asymptomatic patients with B-cell chronic lymphocytic leukemia-like lymphocytosis: the cut-off of 11 × 109/L monoclonal lymphocytes better identifies subgroups with different outcomes Oliveira, A. C.
2014
94 Suppl 1 p. 627-632
artikel
50 Recombinant human thrombopoietin promotes platelet engraftment after haploidentical hematopoietic stem cell transplantation: a prospective randomized controlled trial Han, Ting-ting
2014
94 Suppl 1 p. 117-128
artikel
51 Recommendations for the use of long-term central venous catheter (CVC) in children with hemato-oncological disorders: management of CVC-related occlusion and CVC-related thrombosis. On behalf of the coagulation defects working group and the supportive therapy working group of the Italian Association of Pediatric Hematology and Oncology (AIEOP) Giordano, Paola
2015
94 Suppl 1 p. 1765-1776
artikel
52 Reduced IL-35 levels are associated with increased platelet aggregation and activation in patients with acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation Zhang, Xiaohui
2014
94 Suppl 1 p. 837-845
artikel
53 Repurposing medicinal compounds for blood cancer treatment McCabe, Bronagh
2015
94 Suppl 1 p. 1267-1276
artikel
54 Results of a phase II study of bendamustine and ofatumumab in untreated indolent B cell non-Hodgkin’s lymphoma Czuczman, Myron S.
2015
94 Suppl 1 p. 633-641
artikel
55 Salvage chemotherapy of gemcitabine, dexamethasone, and cisplatin (GDP) for patients with relapsed or refractory peripheral T-cell lymphomas: a consortium for improving survival of lymphoma (CISL) trial Park, Byeong-Bae
2015
94 Suppl 1 p. 1845-1851
artikel
56 Salvage therapy with ARA-C and gemtuzumab ozogamicin in AML patients relapsing after stem cell transplantation Koren-Michowitz, Maya
2014
94 Suppl 1 p. 375-378
artikel
57 Serum hepcidin-25 level linked with high mortality in patients with non-Hodgkin lymphoma Hara, Masaki
2014
94 Suppl 1 p. 603-608
artikel
58 Successful treatment with rivaroxaban of an extended superficial vein thrombosis in a patient with acquired antithrombin deficiency due to Peg-asparaginase treatment Plander, Mark
2015
94 Suppl 1 p. 1257-1258
artikel
59 Sustained remission of blastic plasmacytoid dendritic cell neoplasm after unrelated allogeneic stem cell transplantation—a single center experience Heinicke, Thomas
2014
94 Suppl 1 p. 283-287
artikel
60 Synchronous presentation of monoclonal gammopathy and Fabry nephropathy; diagnostic renal biopsy obviates initiation of myeloma therapy Pokuri, Venkata K.
2015
94 Suppl 1 p. 1067-1068
artikel
61 Synergistic effect of sorafenib and cGvHD in patients with high-risk FLT3-ITD+AML allows long-term disease control after allogeneic transplantation Tschan-Plessl, A.
2015
94 Suppl 1 p. 1899-1905
artikel
62 The Glasgow Prognostic Score as a significant predictor of diffuse large B cell lymphoma treated with R-CHOP in China Li, Xiaoyang
2014
94 Suppl 1 p. 57-63
artikel
63 The incidence, risk factors, and outcomes of primary poor graft function after unmanipulated haploidentical stem cell transplantation Sun, Yu-Qian
2015
94 Suppl 1 p. 1699-1705
artikel
64 The prognostic nutritional index predicts survival for patients with extranodal natural killer/T cell lymphoma, nasal type Chen, Kai-Lin
2015
94 Suppl 1 p. 1389-1400
artikel
65 The treatment outcome of multiple myeloma patients ineligible for hematopoietic transplantation—a single institutional experience in Taiwan Huang, Tzu-Chuan

94 Suppl 1 p. 107-115
artikel
66 Torsade de Pointes during oral arsenic trioxide therapy for acute promyelocytic leukemia in a patient with heart failure Hai, Jo Jo
2014
94 Suppl 1 p. 501-503
artikel
67 Trained clinical nurse specialists proficiently obtain bone marrow aspirates and trephine biopsies in a nearly painless procedure—a prospective evaluation study Naegele, M.
2015
94 Suppl 1 p. 1577-1584
artikel
68 Virus infection in HLA-haploidentical hematopoietic stem cell transplantation: incidence in the context of immune recovery in two different transplantation settings Tischer, Johanna
2015
94 Suppl 1 p. 1677-1688
artikel
                             68 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland